Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis products.
Related Posts
Amazon set to report Q3 earnings after the bell
Wall Street has cheered Amazon CEO Andy Jassy’s cost-cutting efforts, with the company’s shares up about 23% year to date.
Wholesale price measure was flat in February, compared with expected increase
The producer price index was expected to rise 0.3% in February, according to the Dow Jones consensus forecast.